Functional GI & Motility

Disorders of gut-brain interaction are being reframed by Rome IV, high-resolution manometry, and the wireless motility capsule. IBS-D management now integrates eluxadoline, rifaximin re-treatment, and low-FODMAP diets, while linaclotide, plecanatide, and tenapanor anchor IBS-C care. EndoFLIP and HRM with the Chicago Classification 4.0 differentiate achalasia subtypes and EGJ outflow obstruction. Gastroparesis sees renewed interest in prucalopride, ghrelin agonists (relamorelin), and gastric peroral endoscopic myotomy (G-POEM). Sessions also cover cyclic vomiting syndrome, rumination, and the central neuromodulator class for visceral hypersensitivity.